C3.ai initiates a search for a new CEO to replace Thomas Siebel, who will continue as executive chair. Siebel is experiencing significant visual impairment after being diagnosed with an autoimmune ...

The human genome is made up of 23 pairs of chromosomes, the biological blueprints that make humans … well, human. But it ...

AI stock fell on Thursday after software maker C3.ai said its chief executive, Thomas Siebel, will step down for health ...

Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

In a statement, C3.ai, Inc. (NYSE:AI) said that CEO Thomas Siebel has tendered his resignation due to health reasons, effective upon a successor assuming his post.

C3 AI (NYSE: AI), the Enterprise AI application software company, in the course of Q1, has restructured its global sales and ...

HELENA — Thomas Siebel, the software billionaire, philanthropist and founder of the Montana Meth Project, is selling one of his Montana ranches for a steep $45 million — the historic N Bar ...

"After being diagnosed with an autoimmune disease in early 2025, I have experienced significant visual impairment," said Thomas M. Siebel, Chairman and CEO of C3 AI. "For C3 AI to reach its full ...

(“C3 AI,” “C3,” or the “Company”) (NYSE: AI), the Enterprise AI application software company, today announced that it has initiated a search for Mr. Siebel’s successor as Chief Executive Officer of C3 ...

With respect to the TRO motion, Plaintiff focuses on her claims for defamation and seeks an injunction restraining Askew and Boyce from making further defamatory statements concerning Plaintiff or her ...